{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:29:59Z","timestamp":1789180199660,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.kint.2017.06.016","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T03:03:17Z","timestamp":1503543797000},"page":"147-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease"],"prefix":"10.1016","volume":"93","author":[{"given":"Matthew J.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Sugatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Agapova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Gaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Faugere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut H.","family":"Malluche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Hruska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2017.06.016_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jamacardio.2016.4652","article-title":"Absolute rates of heart failure, coronary heart disease, and stroke in chronic kidney disease: An analysis of 3 community-based cohort studies","volume":"2","author":"Bansal","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.kint.2017.06.016_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.06.016_bib3","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2017.06.016_bib4","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2017.06.016_bib5","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2017.06.016_bib6","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.06.016_bib7","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","article-title":"Patterns of FGF-23, DMP1 and MEPE expression in patients with chronic kidney disease","volume":"45","author":"Pereira","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.kint.2017.06.016_bib8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ki.2013.271","article-title":"Early chronic kidney disease-mineral bone disorder stimulates vascular calcification","volume":"85","author":"Fang","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.06.016_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ki.1976.42","article-title":"Bone histology in incipient and advanced renal failure","volume":"9","author":"Malluche","year":"1976","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.06.016_bib10","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.2006101159","article-title":"Reduced Kidney Function as a Risk Factor for Incident Heart Failure: The atherosclerosis risk in communities (ARIC) Study","volume":"18","author":"Kottgen","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.06.016_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.06.016_bib12","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/ki.2010.328","article-title":"Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective","volume":"78","author":"Hu","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.06.016_bib13","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease","volume":"369","author":"de Zeeuw","year":"2013","journal-title":"N\u00a0Eng J Med"},{"key":"10.1016\/j.kint.2017.06.016_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1159\/000362906","article-title":"Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl","volume":"39","author":"Chin","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2017.06.016_bib15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.kint.2016.02.002","article-title":"Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease","volume":"89","author":"Agapova","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.06.016_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-08-0549","article-title":"The biology of activin: recent advances in structure, regulation and function","volume":"202","author":"Xia","year":"2009","journal-title":"Journal Endocrinol"},{"key":"10.1016\/j.kint.2017.06.016_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1478-811X-7-15","article-title":"Activin signaling as an emerging target for therapeutic interventions","volume":"7","author":"Tsuchida","year":"2009","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.kint.2017.06.016_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrneph.2012.259","article-title":"Alport syndrome[mdash]insights from basic and clinical research","volume":"9","author":"Kruegel","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2017.06.016_bib19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","article-title":"X-linked Alport syndrome: Natural history in 195 families and genotype-phenotype correlations in males","volume":"11","author":"Jais","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.06.016_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/PHMT.S35667","article-title":"Long-term management of Alport syndrome in pediatric patients","volume":"4","author":"Kashtan","year":"2013","journal-title":"Pediatr Health Med Ther"},{"key":"10.1016\/j.kint.2017.06.016_bib21","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1523-1755.2000.00358.x","article-title":"Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation","volume":"58","author":"van der Loop","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.06.016_bib22","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/ki.2014.326","article-title":"Pathology vs. molecular genetics: (re)defining the spectrum of Alport syndrome","volume":"86","author":"Miner","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.06.016_bib23","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1046\/j.1523-1755.2002.00379.x","article-title":"COL4A3\/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome","volume":"61","author":"Longo","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.06.016_bib24","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/01.ASN.0000130562.90255.8F","article-title":"Mouse model of X-Linked Alport syndrome","volume":"15","author":"Rheault","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.06.016_bib25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1523-1755.2003.00779.x","article-title":"Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome","volume":"63","author":"Gross","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.06.016_bib26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5527\/wjn.v3.i4.230","article-title":"Searching for a treatment for Alport syndrome using mouse models","volume":"3","author":"Katayama","year":"2014","journal-title":"World J Nephrol"},{"key":"10.1016\/j.kint.2017.06.016_bib27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1681\/ASN.2012020148","article-title":"Expert Guidelines for the Management of Alport Syndrome and Thin Basement Membrane Nephropathy","volume":"24","author":"Savige","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.06.016_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jbmr.516","article-title":"Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease","volume":"27","author":"Stubbs","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2017.06.016_bib29","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1161\/circ.104.16.1881","article-title":"Vascular calcification: pathobiology of a multifaceted disease","volume":"104","author":"Demer","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2017.06.016_bib30","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1681\/ASN.2013111209","article-title":"The kidney is the principal organ mediating klotho effects","volume":"25","author":"Lindberg","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.06.016_bib31","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1681\/ASN.2014050465","article-title":"Klotho and phosphate are modulators of pathologic uremic cardiac remodeling","volume":"26","author":"Hu","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.06.016_bib32","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1681\/ASN.2014040325","article-title":"Soluble klotho protects against uremic cardiomyopathy independently of fibroblast growth factor 23 and phosphate","volume":"26","author":"Xie","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"suppl 1","key":"10.1016\/j.kint.2017.06.016_bib33","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1681\/ASN.V13suppl_1s14","article-title":"Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function","volume":"13","author":"Morrissey","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.06.016_bib34","doi-asserted-by":"crossref","first-page":"F130","DOI":"10.1152\/ajprenal.2000.279.1.F130","article-title":"Osteogenic protein-1 (OP-1) prevents renal fibrogenesis associated with ureteral obstruction","volume":"279","author":"Hruska","year":"2000","journal-title":"Am J Phys (Renal)"},{"key":"10.1016\/j.kint.2017.06.016_bib35","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.V12112392","article-title":"Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy","volume":"12","author":"Wang","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.06.016_bib36","doi-asserted-by":"crossref","first-page":"F1641","DOI":"10.1152\/ajprenal.00179.2007","article-title":"BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury","volume":"293","author":"Mitu","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2017.06.016_bib37","doi-asserted-by":"crossref","first-page":"F1006","DOI":"10.1152\/ajprenal.00382.2002","article-title":"BMP7 antagonizes TGF-beta-dependent fibrogenesis in mesangial cells","volume":"284","author":"Wang","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2017.06.016_bib38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-[beta]: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2017.06.016_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5000054","article-title":"Renal fibrosis: New insights into the pathogenesis and therapeutics","volume":"69","author":"Liu","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.06.016_bib40","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1681\/ASN.2013101143","article-title":"Translational profiles of medullary myofibroblasts during kidney fibrosis","volume":"25","author":"Grgic","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.06.016_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jcb.10613","article-title":"Activin A stimulates I kappaB-alpha\/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors","volume":"90","author":"Sugatani","year":"2003","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.kint.2017.06.016_bib42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/endo.143.1.8580","article-title":"Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures","volume":"143","author":"Gaddy-Kurten","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.kint.2017.06.016_bib43","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/jbmr.142","article-title":"Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in\u00a0vivo","volume":"25","author":"Chantry","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2017.06.016_bib44","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.kint.2016.07.039","article-title":"Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease","volume":"91","author":"Sugatani","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.06.016_bib45","doi-asserted-by":"crossref","first-page":"e2942","DOI":"10.1371\/journal.pone.0002942","article-title":"Control of bone mass and remodeling by pth receptor signaling in osteocytes","volume":"3","author":"O'Brien","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.kint.2017.06.016_bib46","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jbmr.1547","article-title":"Osteocyte RANKL: New insights into the control of bone remodeling","volume":"27","author":"Xiong","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.kint.2017.06.016_bib47","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nm.3917","article-title":"Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice","volume":"21","author":"Dankbar","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2017.06.016_bib48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/cr.2008.326","article-title":"TGF-[beta] signaling in vascular biology and dysfunction","volume":"19","author":"Goumans","year":"2009","journal-title":"Cell Res"},{"key":"10.1016\/j.kint.2017.06.016_bib49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4331\/wjbc.v3.i3.41","article-title":"Transforming growth factor-\u03b2 and smooth muscle differentiation","volume":"3","author":"Guo","year":"2012","journal-title":"World J Biol Chem"},{"key":"10.1016\/j.kint.2017.06.016_bib50","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.RES.0000141775.67189.98","article-title":"Pathophysiology of vascular calcification in chronic kidney disease","volume":"95","author":"Moe","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2017.06.016_bib51","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.ATV.0000059406.92165.31","article-title":"Osteo\/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification","volume":"23","author":"Tyson","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2017.06.016_bib52","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/CIRCRESAHA.108.183053","article-title":"Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries","volume":"104","author":"Speer","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2017.06.016_bib53","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/cvr\/cvw205","article-title":"Runx2 deletion in smooth muscle cells inhibits vascular osteochondrogenesis and calcification but not atherosclerotic lesion formation","volume":"112","author":"Lin","year":"2016","journal-title":"Cardiovas Res"},{"key":"10.1016\/j.kint.2017.06.016_bib54","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/01.RES.85.10.931","article-title":"Human activin-A is expressed in the atherosclerotic lesion and promotes the contractile phenotype of smooth muscle cells","volume":"85","author":"Engelse","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2017.06.016_bib55","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.stem.2016.08.001","article-title":"Adventitial MSC-like cells are progenitors of vascular smooth muscle cells and drive vascular calcification in chronic kidney disease","volume":"19","author":"Kramann","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.kint.2017.06.016_bib56","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/386078a0","article-title":"Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein","volume":"386","author":"Luo","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.kint.2017.06.016_bib57","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.kint.2017.06.016_bib58","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ki.2009.83","article-title":"Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin","volume":"75","author":"El-Abbadi","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.06.016_bib59","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1159\/000299794","article-title":"Vascular calcification in animal models of CKD: a review","volume":"31","author":"Shobeiri","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2017.06.016_bib60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/jcmm.12373","article-title":"BMP-9 regulates the osteoblastic differentiation and calcification of vascular smooth muscle cells through an ALK1 mediated pathway","volume":"19","author":"Zhu","year":"2015","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.kint.2017.06.016_bib61","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.bbadis.2013.05.016","article-title":"The ALK-1\/Smad1 pathway in cardiovascular physiopathology. A new target for therapy?","volume":"1832","author":"Gonz\u00e1lez-N\u00fa\u00f1ez","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.kint.2017.06.016_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4358","article-title":"ACVRIR206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A","volume":"7","author":"Hatsell","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.kint.2017.06.016_bib63","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrcardio.2015.156","article-title":"Targeting BMP signalling in cardiovascular disease and anaemia","volume":"13","author":"Morrell","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.kint.2017.06.016_bib64","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.cell.2013.04.015","article-title":"Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy","volume":"153","author":"Loffredo","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.kint.2017.06.016_bib65","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nbt.3557","article-title":"No longer going to waste","volume":"34","author":"Garber","year":"2016","journal-title":"Nat Biotech"},{"issue":"suppl 4","key":"10.1016\/j.kint.2017.06.016_bib66","doi-asserted-by":"crossref","first-page":"iv124","DOI":"10.1093\/ndt\/gfu028","article-title":"Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies","volume":"29","author":"Gross","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2017.06.016_bib67","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI39569","article-title":"Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome","volume":"120","author":"Tanaka","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2017.06.016_bib68","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1681\/ASN.2015030287","article-title":"Inhibition of activin signaling slows progression of polycystic kidney disease","volume":"27","author":"Leonhard","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.06.016_bib69","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.bone.2010.01.370","article-title":"A\u00a0soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys","volume":"46","author":"Lotinun","year":"2010","journal-title":"Bone"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253817304763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253817304763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T10:28:01Z","timestamp":1641464881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253817304763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0085253817304763"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2017.06.016","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2017.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}